Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (171-180 of 1,137) with videos related to

Pageof 114
Sort By:
Critical Pathways in Cardiology|March 11, 2010
The use and limitations of unfractionated heparinAmar Krishnaswamy, A Michael Lincoff, Christopher P Cannon
The New England Journal of Medicine|July 9, 2005
Intensive lipid lowering with atorvastatin in coronary diseaseChristopher P Cannon, Sabina A Murphy, Eugene Braunwald
Annals of Internal Medicine|September 12, 1998
The antiplatelet effects of ticlopidine and clopidogrelP J Sharis, C P Cannon, J Loscalzo
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2011
Construction, expression, and purification of chimeric protein reagents based on immunoglobulin fc regionsJohn P Cannon, Marci O'Driscoll, Gary W Litman
Journal of the American College of Cardiology|March 27, 2010
High-density lipoprotein and coronary heart disease: current and future therapiesPradeep Natarajan, Kausik K Ray, Christopher P Cannon
European Journal of Clinical Pharmacology|January 1, 1983
Nifedipine in the treatment of hypertensionF Brennan, M Flanagan, S Blake, et al.
Clinical Cardiology|June 24, 2005
Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trialJames L Januzzi, Jacqueline Buros, Christopher P Cannon, et al.
The American Journal of Cardiology|November 28, 2006
Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?Kausik K Ray, Christopher P Cannon, Peter Ganz
Expert Opinion on Drug Safety|September 28, 2010
Bleeding complications of unfractionated heparinAmar Krishnaswamy, A Michael Lincoff, Christopher P Cannon
International Journal of Clinical Practice|June 20, 2007
Recent trials of lipid loweringK K Ray, C P Cannon, E Braunwald
Pageof 114

Showing results (171-180 of 1,137) with videos related to

Sort By:
Pageof 114
Critical Pathways in Cardiology|March 11, 2010
The use and limitations of unfractionated heparinAmar Krishnaswamy, A Michael Lincoff, Christopher P Cannon
The New England Journal of Medicine|July 9, 2005
Intensive lipid lowering with atorvastatin in coronary diseaseChristopher P Cannon, Sabina A Murphy, Eugene Braunwald
Annals of Internal Medicine|September 12, 1998
The antiplatelet effects of ticlopidine and clopidogrelP J Sharis, C P Cannon, J Loscalzo
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2011
Construction, expression, and purification of chimeric protein reagents based on immunoglobulin fc regionsJohn P Cannon, Marci O'Driscoll, Gary W Litman
Journal of the American College of Cardiology|March 27, 2010
High-density lipoprotein and coronary heart disease: current and future therapiesPradeep Natarajan, Kausik K Ray, Christopher P Cannon
European Journal of Clinical Pharmacology|January 1, 1983
Nifedipine in the treatment of hypertensionF Brennan, M Flanagan, S Blake, et al.
Clinical Cardiology|June 24, 2005
Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trialJames L Januzzi, Jacqueline Buros, Christopher P Cannon, et al.
The American Journal of Cardiology|November 28, 2006
Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?Kausik K Ray, Christopher P Cannon, Peter Ganz
Expert Opinion on Drug Safety|September 28, 2010
Bleeding complications of unfractionated heparinAmar Krishnaswamy, A Michael Lincoff, Christopher P Cannon
International Journal of Clinical Practice|June 20, 2007
Recent trials of lipid loweringK K Ray, C P Cannon, E Braunwald
Pageof 114